Discover
ADVM
Adverum Biotechnologies, Inc.
4.36
1 x 3.63
1 x 4.79
bid
ask
+
0.00
0.00%
1 @ 09:30 AM
4.49 +0.13 (2.98%)
| Ytd | -6.64% | |
| 1y | -26.23% |
4.23
day range
4.38
52 week range
| Open | 4.24 | Prev Close | 4.36 | Low | 4.23 | High | 4.38 | Mkt Cap | N/A |
| Vol | 675.98K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -0.89 |
| Beta | 1.01 | Short Ratio | 5.53 | Inst. Own | 79.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 29.71 |
| Income Statement | |||
| Operating Expenses | 48.02M | ||
| Research and Development Expense | 38.91M | ||
| Selling, General and Administrative Expense | 9.11M | ||
| Operating Income | -48.02M | ||
| Net Income | -47.65M | ||
| Net Income Common Stock | -47.65M | ||
| Net Income Common Stock (USD) | -47.65M | ||
| Consolidated Income | -47.65M | ||
| Earnings per Basic Share | -2.03 | ||
| Earnings per Basic Share (USD) | -2.03 | ||
| Earnings per Diluted Share | -2.03 | ||
| Earning Before Interest & Taxes (EBIT) | -47.65M | ||
| Earning Before Interest & Taxes (USD) | -47.65M | ||
| Weighted Average Shares | 23.49M | ||
| Weighted Average Shares Diluted | 23.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.04M | ||
| Cash and Equivalents (USD) | 28.04M | ||
| Current Assets | 28.91M | ||
| Property, Plant & Equipment Net | 39.49M | ||
| Total Assets | 72.40M | ||
| Total Debt | 83.13M | ||
| Current Liabilities | 44.75M | ||
| Debt Non-Current | 83.13M | ||
| Total Liabilities | 128.05M | ||
| Accumulated Retained Earnings (Deficit) | -1.21B | ||
| Accumulated Other Comprehensive Income | -440.00K | ||
| Shareholders Equity | -55.65M | ||
| Shareholders Equity (USD) | -55.65M | ||
| Assets Non-Current | 43.49M | ||
| Total Debt (USD) | 83.13M | ||
| Liabilities Non-Current | 83.31M | ||
| Trade and Non-Trade Payables | 12.46M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 548.00K | ||
| Net Cash Flow from Financing | 9.90M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.36M | ||
| Capital Expenditure | -142.00K | ||
| Issuance (Purchase) of Equity Shares | 9.90M | ||
| Net Cash Flow from Investing | 1.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.00M | ||
| Net Cash Flow from Operations | -28.11M | ||
| Share Based Compensation | 2.35M | ||